Katrina A.B. Goddard, PhD

home / authors / katrina-a-b-goddard-phd

Articles

August 11th 2021

Impact of Expanded Carrier Screening on Health Care Utilization

Tia L. Kauffman, MPH John F. Dickerson, PhD Frances L. Lynch, PhD Michael C. Leo, PhD Elizabeth Shuster, MS Benjamin S. Wilfond, MD Patricia Himes, MS, CGC Marian J. Gilmore, MS, CGC Nancy J. Rollins, BA Katrina A.B. Goddard, PhD

This study shows little evidence of harms or increased health care utilization for people receiving negative (normal) results of expanded carrier screening through genome sequencing.

November 20th 2012

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

Katrina A.B. Goddard, PhD Erin J. Aiello Bowles, MPH Heather Spencer Feigelson, PhD, MPH Laurel A. Habel, PhD Sharon Hensley Alford, PhD Catherine A. McCarty, PhD, MPH Larissa Nekhlyudov, MD, MPH Adedayo A. Onitilo, MD, MSCR, FACP Alanna K. Rahm, PhD, MS Jennifer A. Webster, MS

Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.